A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk

British Journal of Haematology

Volumn 152, Issue 6, 2011, Pages 721-726

  Hosgood, H Dean ^a   Purdue, Mark P ^a   Wang, Sophia S ^a,b   Zheng, Tongzhang ^c   Morton, Lindsay M ^a   Lan, Qing ^a   Menashe, Idan ^a   Zhang, Yawei ^c   Cerhan, James R ^d   Grulich, Andrew ^e   Cozen, Wendy ^f   Yeager, Meredith ^a   Holford, Theodore R ^c   Vajdic, Claire M ^g   Davis, Scott ^h   Leaderer, Brian ^c   Kricker, Anne ⁱ   Schenk, Maryjean ^j   Zahm, Shelia H ^a   Chatterjee, Nilanjan ^a   Chanock, Stephen J ^a   Rothman, Nathaniel ^a   Hartge, Patricia ^a   Armstrong, Bruce ⁱ   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b Division of Etiology   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j WAYNE STATE UNIVERSITY   (United States)

more..

Author keywords

Genetic variation; Immune; Innate immunity; Non Hodgkin lymphoma; Single nucleotide polymorphisms

Indexed keywords

ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CXCR1 GENE; CXCR2 GENE; FC REGION RECEPTOR IIA GENE; FOLLICULAR LYMPHOMA; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL1R1 GENE; IL1R2 GENE; IL1RN GENE; IL6R GENE; IMMUNOGENETICS; INNATE IMMUNITY; INTERCELLULAR ADHESION MOLECULE 1 GENE; INTERCELLULAR ADHESION MOLECULE 4 GENE; INTERCELLULAR ADHESION MOLECULE 5 GENE; INTERLEUKIN 15 GENE; INTERLEUKIN 1A GENE; INTERLEUKIN 1B GENE; INTERLEUKIN 6 GENE; INTERLEUKIN 8 GENE; JAK3 GENE; LARGE CELL CARCINOMA; LYMPHOCYTOMA; MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; IMMUNITY, INNATE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG;

EID: 79952003247     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08518.x     Document Type: Article

References (41)

1. Andrie, E., Michos, A., Kalampoki, V., Pourtsidis, A., Moschovi, M., Polychronopoulou, S., Athanasiadou-Piperopoulou, F., Kalmanti, M., Hatzakis, A., Paraskevis, D., Nieters, A. & Petridou, E.T. (2009) Genetic variants in immunoregulatory genes and risk for childhood lymphomas. European Journal of Haematology, 83, 334-342.
2. Asano, K., Matsushita, T., Umeno, J., Hosono, N., Takahashi, A., Kawaguchi, T., Matsumoto, T., Matsui, T., Kakuta, Y., Kinouchi, Y., Shimosegawa, T., Hosokawa, M., Arimura, Y., Shinomura, Y., Kiyohara, Y., Tsunoda, T., Kamatani, N., Iida, M., Nakamura, Y. & Kubo, M. (2009) A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nature Genetics, 41, 1325-1329.
3. Bastion, Y., Sebban, C., Berger, F., Felman, P., Salles, G., Dumontet, C., Bryon, P.A. & Coiffier, B. (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. Journal of Clinical Oncology, 15, 1587-1594.
4. Bhatti, P., Sigurdson, A.J., Wang, S.S., Chen, J., Rothman, N., Hartge, P., Bergen, A.W. & Landi, M.T. (2005) Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiology, Biomarkers and Prevention, 14, 2449-2453.
5. Bonizzi, G. & Karin, M. (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends in Immunology, 25, 280-288.
6. Bournazos, S., Woof, J.M., Hart, S.P. & Dransfield, I. (2009) Functional and clinical consequences of Fc receptor polymorphic and copy number variants. Clinical & Experimental Immunology, 157, 244-254.
7. Carlson, C.S., Eberle, M.A., Rieder, M.J., Yi, Q., Kruglyak, L. & Nickerson, D.A. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. American Journal of Human Genetics, 74, 106-120.
8. Chatterjee, N., Hartge, P., Cerhan, J.R., Cozen, W., Davis, S., Ishibe, N., Colt, J., Goldin, L. & Severson, R.K. (2004) Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiology, Biomarkers and Prevention, 13, 1415-1421.
9. Chen, B.E., Sakoda, L.C., Hsing, A.W. & Rosenberg, P.S. (2006) Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genetic Epidemiology, 30, 495-507.
10. Elahi, M.M., McMillan, D.C., McArdle, C.S., Angerson, W.J., Soukop, M., Johnstone, J. & Sattar, N. (2005) The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma. Medical Science Monitor, 11, CR75-CR78.
11. Forrest, M.S., Skibola, C.F., Lightfoot, T.J., Bracci, P.M., Willett, E.V., Smith, M.T., Holly, E.A. & Roman, E. (2006) Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. British Journal of Haematology, 134, 180-183.
12. Ghosh, S., May, M.J. & Kopp, E.B. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology, 16, 225-260.
13. Hoeft, B., Becker, N., Deeg, E., Beckmann, L. & Nieters, A. (2008) Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma. Cancer Causes and Control, 19, 163-173.
14. Hofmann, S.R., Ettinger, R., Zhou, Y.J., Gadina, M., Lipsky, P., Siegel, R., Candotti, F. & O'Shea, J.J. (2002) Cytokines and their role in lymphoid development, differentiation and homeostasis. Current Opinion in Allergy and Clinical Immunology, 2, 495-506.
15. Huang, B.E., Amos, C.I. & Lin, D.Y. (2007) Detecting haplotype effects in genomewide association studies. Genetic Epidemiology, 31, 803-812.
16. Kabelitz, D. & Medzhitov, R. (2007) Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Current Opinion in Immunology, 19, 1-3.
17. Karassa, F.B., Trikalinos, T.A. & Ioannidis, J.P. (2004) The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Biomedicine and Pharmacotherapy, 58, 286-291.
18. Koene, H.R., Kleijer, M., Algra, J., Roos, D., von dem Borne, A.E. & de Haas, M. (1997) Fcgamma RIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell fcgamma RIIIa, independently of the Fcgamma RIIIa-48L/R/H phenotype. Blood, 90, 1109-1114.
19. Lan, Q., Zheng, T., Rothman, N., Zhang, Y., Wang, S.S., Shen, M., Berndt, S.I., Zahm, S.H., Holford, T.R., Leaderer, B., Yeager, M., Welch, R., Boyle, P., Zhang, B., Zou, K., Zhu, Y. & Chanock, S. (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood, 107, 4101-4108.
20. Langer, H.F. & Chavakis, T. (2009) Leukocyte ΓÇô endothelial interactions in inflammation. Journal of Cellular and Molecular Medicine, 13, 1211-1220.
21. Lehrnbecher, T., Foster, C.B., Zhu, S., Leitman, S.F., Goldin, L.R., Huppi, K. & Chanock, S.J. (1999) Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood, 94, 4220-4232.
22. Lucey, D.R., Clerici, M. & Shearer, G.M. (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clinical Microbiology Reviews, 9, 532-562.
23. Mantovani, A., Schioppa, T., Porta, C., Allavena, P. & Sica, A. (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer and Metastasis Reviews, 25, 315-322.
24. Maxwell, K.F., Powell, M.S., Hulett, M.D., Barton, P.A., McKenzie, I.F.C., Garrett, T.P.J. & Hogarth, P.M. (1999) Crystal structure of the human leukocyte Fc receptor, Fc[gamma]RIIa. Nature Structural & Molecular Biology, 6, 437-442.
25. Morton, L.M., Turner, J.J., Cerhan, J.R., Linet, M.S., Treseler, P.A., Clarke, C.A., Jack, A., Cozen, W., Maynadie, M., Spinelli, J.J., Costantini, A.S., Rudiger, T., Scarpa, A., Zheng, T. & Weisenburger, D.D. (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood, 110, 695-708.
26. Muller, A.M., Ihorst, G., Mertelsmann, R. & Engelhardt, M. (2005) Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Annals of Hematology, 84, 1-12.
27. Parker, D., Alison, D.L., Barnard, D.L., Child, J.A., Dovey, G., Farish, J., Norfolk, D.R., O'Brien, C.J., Parapia, L.A. & Sharp, J. (1994) Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level. Hematological Oncology, 12, 15-27.
28. Purdue, M.P., Lan, Q., Kricker, A., Grulich, A.E., Vajdic, C.M., Turner, J., Whitby, D., Chanock, S., Rothman, N. & Armstrong, B.K. (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis, 28, 704-712.
29. Rollinson, S., Levene, A.P., Mensah, F.K., Roddam, P.L., Allan, J.M., Diss, T.C., Roman, E., Jack, A., MacLennan, K., Dixon, M.F. & Morgan, G.J. (2003) Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood, 102, 1007-1011.
30. Rothman, N., Skibola, C.F., Wang, S.S., Morgan, G., Lan, Q., Smith, M.T., Spinelli, J.J., Willett, E., De Sanjose S., Cocco, P., Berndt, S.I., Brennan, P., Brooks-Wilson, A., Wacholder, S., Becker, N., Hartge, P., Zheng, T., Roman, E., Holly, E.A., Boffetta, P., Armstrong, B., Cozen, W., Linet, M., Bosch, F.X., Ennas, M.G., Holford, T.R., Gallagher, R.P., Rollinson, S., Bracci, P.M., Cerhan, J.R., Whitby, D., Moore, P.S., Leaderer, B., Lai, A., Spink, C., Davis, S., Bosch, R., Scarpa, A., Zhang, Y., Severson, R.K., Yeager, M., Chanock, S. & Nieters, A. (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. The Lancet Oncology, 7, 27-38.
31. Salmon, J.E., Millard, S., Schachter, L.A., Arnett, F.C., Ginzler, E.M., Gourley, M.F., Ramsey-Goldman, R., Peterson, M.G. & Kimberly, R.P. (1996) Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. Journal of Clinical Investigation, 97, 1348-1354.
32. *2) is associated with enhanced IL-1beta production in vitro. Scandinavian Journal of Immunology, 47, 195-198.
33. Schaid, D.J., Rowland, C.M., Tines, D.E., Jacobson, R.M. & Poland, G.A. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. American Journal of Human Genetics, 70, 425-434.
34. Skibola, C.F., Bracci, P.M., Nieters, A., Brooks-Wilson, A., de Sanjosé, S., Hughes, A.M., Cerhan, J.R., Skibola, D.R., Purdue, M., Kane, E., Lan, Q., Foretova, L., Schenk, M., Spinelli, J.J., Slager, S.L., De Roos, A.J., Smith, M.T., Roman, E., Cozen, W., Boffetta, P., Kricker, A., Zheng, T., Lightfoot, T., Cocco, P., Benavente, Y., Zhang, Y., Hartge, P., Linet, M.S., Becker, N., Brennan, P., Zhang, L., Armstrong, B., Smith, A., Shiao, R., Novak, A.J., Maynadie, M., Chanock, S.J., Staines, A., Holford, T.R., Holly, E.A., Rothman, N. & Wang, S.S. (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. American Journal of Epidemiology, 171, 267-276.
35. Wang, S.S., Cerhan, J.R., Hartge, P., Davis, S., Cozen, W., Severson, R.K., Chatterjee, N., Yeager, M., Chanock, S.J. & Rothman, N. (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-hodgkin lymphoma. Cancer Research, 66, 9771-9780.
36. Wang, S.S., Slager, S.L., Brennan, P., Holly, E.A., De Sanjose, S., Bernstein, L., Boffetta, P., Cerhan, J.R., Maynadie, M., Spinelli, J.J., Chiu, B.C., Cocco, P.L., Mensah, F., Zhang, Y., Nieters, A., Dal, M.L., Bracci, P.M., Costantini, A.S., Vineis, P., Severson, R.K., Roman, E., Cozen, W., Weisenburger, D., Davis, S., Franceschi, S., La, V.C., Foretova, L., Becker, N., Staines, A., Vornanen, M., Zheng, T. & Hartge, P. (2007) Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood, 109, 3479-3488.
37. Wang, S.S., Purdue, M.P., Cerhan, J.R., Zheng, T., Menashe, I., Armstrong, B.K., Lan, Q., Hartge, P., Kricker, A., Zhang, Y., Morton, L.M., Vajdic, C.M., Holford, T.R., Severson, R.K., Grulich, A., Leaderer, B.P., Davis, S., Cozen, W., Yeager, M., Chanock, S.J., Chatterjee, N. & Rothman, N. (2009) Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS ONE, 4, e5360.
38. Warmerdam, P.A., van de Winkel, J.G., Gosselin, E.J. & Capel, P.J. (1990) Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). The Journal of Experimental Medicine, 172, 19-25.
39. Warmerdam, P.A., van de Winkel, J.G., Vlug, A., Westerdaal, N.A. & Capel, P.J. (1991) A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. The Journal of Immunology, 147, 1338-1343.
40. Witkin, S.S., Gerber, S. & Ledger, W.J. (2002) Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clinical Infectious Diseases, 34, 204-209.
41. Wu, M.S., Shun, C.T., Huang, S.P., Cheng, A.L., Chen, L.T. & Lin, J.T. (2004) Effect of interleukin-1 beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma. Haematologica, 89, 1015-1017.